Head and Neck Squamous Cell Carcinoma of Unknown Primary
Associated Genetic Biomarkers
There are 9 clinical trials for head and neck squamous cell carcinoma of unknown primary, of which 9 are open and 0 are completed or closed. Of the trials that contain head and neck squamous cell carcinoma of unknown primary as an inclusion criterion, 2 are phase 1 (2 open), 1 is phase 1/phase 2 (1 open), 4 are phase 2 (4 open), 1 is phase 2/phase 3 (1 open), and 1 is no phase specified (1 open).
Cetuximab, radiation therapy, and cisplatin are the most common interventions in head and neck squamous cell carcinoma of unknown primary clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.